Quaternized chitosan derivatives inhibit growth and affect biofilm formation of Staphylococcus aureus

Alex Miranda1, Nichole D Brandquist2, Kristen Johnson3

  • 1Department of Chemistry, University of Nebraska at Omaha, Omaha, NE, USA.

Scientific Reports
|August 12, 2025
PubMed

Insights

Modified chitosan derivatives show potent antimicrobial activity against antibiotic-resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). These novel materials effectively inhibit bacterial growth and biofilm formation, offering a promising alternative to conventional antibiotics.

Area of Science:

  • Biomaterials Science
  • Microbiology
  • Infectious Diseases

Background:

  • Antimicrobial resistance (AMR) is a critical global health challenge, limiting treatment options for bacterial infections.
  • Methicillin-resistant Staphylococcus aureus (MRSA) presents significant treatment difficulties due to its resistance to beta-lactam antibiotics and biofilm-forming capabilities.
  • Conventional antibiotics have limitations, including side effects and the potential to drive further resistance.

Purpose of the Study:

  • To evaluate the antibacterial efficacy of quaternized chitosan derivatives against antimicrobial-resistant Staphylococcus aureus strains.
  • To investigate the impact of modified chitosan on bacterial growth and biofilm development.
  • To explore the potential of these derivatives as alternatives to traditional antibiotics in medical applications.

Main Methods:

  • Synthesis and characterization of quaternized chitosan derivatives with enhanced positive charge density and hydrophobic moieties.
  • Assessment of antibacterial activity against methicillin-sensitive (MSSA) and MRSA strains.
  • Evaluation of biofilm inhibition using nanofibrous materials composed of polyethylene oxide and hexyl-modified chitosan.

Main Results:

  • Quaternized chitosan derivatives significantly inhibited the growth of both MSSA and MRSA strains.
  • Nanofibrous materials incorporating hexyl-modified chitosan demonstrated significant disruption of S. aureus biofilm formation.
  • These modified chitosan materials led to a substantial accumulation of dead bacterial cells within biofilms.

Conclusions:

  • Modified chitosan derivatives exhibit strong potential as effective antimicrobial agents against resistant bacterial strains.
  • These materials are promising for surface treatments and medical device coatings, especially in biofilm-prone environments.
  • This research offers a viable alternative to conventional antibiotics for combating challenging bacterial infections.